Artemis Medicare Services Ltd Stock Price Today (NSE: ARTEMISMED)
Fundamental Score
Artemis Medicare Services Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Artemis Medicare Services Ltd share price today is ₹276.20, up +1.92% on NSE/BSE as of 17 July 2026. Artemis Medicare Services Ltd (ARTEMISMED) is a Small-cap company in the Hospital sector with a market capitalisation of ₹4.38K (Cr). The 52-week high for ARTEMISMED share price is ₹297.50 and the 52-week low is ₹203.35. At a P/E ratio of 41.39x, ARTEMISMED is currently trading below its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 11.88% and a debt-to-equity ratio of 0.28.
Artemis Medicare Services Ltd Share Price Chart — NSE/BSE Historical Performance
Artemis Medicare Services Ltd share price chart: 4.50% return over the past month. 52-week high ₹297.50, 52-week low ₹203.35.
Artemis Medicare Services Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹271.05 | ₹279.80 | ₹271.05 | ₹276.20 | 1.48L (Cr) | |
| ₹277.80 | ₹284.00 | ₹269.50 | ₹271.00 | 2.28L (Cr) | |
| ₹275.00 | ₹278.90 | ₹271.55 | ₹277.40 | 1.72L (Cr) | |
| ₹268.95 | ₹279.15 | ₹268.30 | ₹277.00 | 3.25L (Cr) | |
| ₹262.96 | ₹268.60 | ₹262.96 | ₹267.55 | 1.90L (Cr) | |
| ₹271.14 | ₹271.59 | ₹261.56 | ₹263.06 | 1.95L (Cr) | |
| ₹277.43 | ₹277.88 | ₹270.99 | ₹272.54 | 1.35L (Cr) | |
| ₹261.46 | ₹281.38 | ₹259.06 | ₹275.44 | 7.72L (Cr) | |
| ₹261.40 | ₹264.00 | ₹259.00 | ₹259.85 | 87.07K (Cr) | |
| ₹261.55 | ₹265.00 | ₹258.40 | ₹259.80 | 1.21L (Cr) |
Artemis Medicare Services Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹263.65 | ₹284.00 | ₹258.40 | ₹276.20 | +4.76% | |
| ₹276.30 | ₹277.60 | ₹253.20 | ₹264.95 | -4.11% | |
| ₹244.13 | ₹295.00 | ₹243.01 | ₹273.36 | +11.97% | |
| ₹207.50 | ₹247.10 | ₹207.50 | ₹244.13 | +17.65% | |
| ₹234.12 | ₹237.35 | ₹203.35 | ₹205.51 | -12.22% | |
| ₹245.00 | ₹249.00 | ₹210.06 | ₹239.90 | -2.08% | |
| ₹271.95 | ₹280.60 | ₹221.00 | ₹247.95 | -8.83% | |
| ₹287.90 | ₹295.00 | ₹261.55 | ₹271.05 | -5.85% | |
| ₹247.56 | ₹297.50 | ₹240.35 | ₹285.46 | +15.31% | |
| ₹234.16 | ₹254.60 | ₹222.05 | ₹247.56 | +5.72% | |
| ₹219.10 | ₹251.77 | ₹219.10 | ₹234.18 | +6.88% | |
| ₹239.05 | ₹256.60 | ₹217.83 | ₹218.98 | -8.40% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Small-cap hospital chain with aggressive expansion plans faces high promoter pledging and liquidity risk.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Artemis Medicare Services Ltd. experienced a volatile period. On March 30, 2026, the stock fell to a 52-week low of However, it rebounded strongly on April 1, 2026, with a 7.87% surge, closing at The week closed on April 3, 2026, at , a 3.25% gain for the week, outperforming the Sensex. The trading window closed on April 1, 2026, in anticipation of Q4 results.
CORE STORY (THE REAL GAME)
Artemis is a small-cap hospital chain attempting aggressive expansion while managing promoter pledging risk. The market is trying to figure out if they can scale without imploding.
- Raipur facility commissioning in April 2026
- Q3 FY26 showed strong profitability surge
- Technical rebound from 52-week low
- Successful commissioning and ramp-up of Raipur hospital
- Significant order wins or contracts
- Reduction in promoter pledging
- High promoter pledging (44.53%)
- Small-cap liquidity risk
- Expansion execution risk
FII increased stake significantly (Δ 12.24%), while DII decreased (Δ -1.41%), indicating mixed institutional sentiment.
Potential increase in hospital bills and medicine costs due to geopolitical tensions (Iran War).
Raipur facility commissioning scheduled for April 2026.
Free Cash Flow 5Y: ₹33.75 Cr, indicating limited cash generation.
Next 3-6 months hinge on successful Raipur facility launch and Q4 results. Monitor promoter pledging and liquidity closely.
Primary Thesis Risk
Promoter pledging could trigger a collapse if the stock falters.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Artemis Medicare Services Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Artemis Medicare Services Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ARTEMISMED across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Operating Margins (15.33%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (27.37%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (16.61%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (21.41% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (69.40% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (75.56% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.28)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (6.26x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹67.59 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (58.39%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Premium Valuation Risk (P/E: 41.39x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Artemis Medicare Services Ltd vs Hospital Peers
Peer Comparison - Hospital
Compare Artemis Medicare Services Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Artemis Medicare Services LtdArtemis Medicar...Selected✓ ARTEMISMED • 542919 | 69.5/100 | ₹276.20₹276 | ₹4376.46₹4376.46 | 41.39Average 41.4 Average | 11.88%Average 11.88% Average | 14.53%Average 14.53% Average | 0.28Excellent 0.3 Excellent | 75.56%Excellent 75.56% Excellent | 21.41%Excellent 21.41% Excellent | 0.16% |
Apollo Hospitals Enterprise LtdApollo Hospital... APOLLOHOSP • 508869 | 62.1/100 | ₹8934.00₹8934 | ₹128448.55₹128448.55 | 65.68Average 65.7 Average | 22.11%Excellent 22.11% Excellent | 17.89%Good 17.89% Good | 0.90Good 0.9 Good | 77.79%Excellent 77.79% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LtdMax Healthcare ... MAXHEALTH • 543220 | 56.9/100 | ₹1102.70₹1103 | ₹107422.79₹107422.79 | 72.42Average 72.4 Average | 14.74%Average 14.74% Average | 14.71%Average 14.71% Average | 0.32Excellent 0.3 Excellent | 60.01%Excellent 60.01% Excellent | 27.27%Excellent 27.27% Excellent | 0.18% |
Fortis Healthcare LtdFortis Healthca... FORTIS • 532843 | 56.8/100 | ₹976.15₹976 | ₹73687.64₹73687.64 | 69.60Average 69.6 Average | 11.26%Average 11.26% Average | 13.47%Average 13.47% Average | 0.35Excellent 0.3 Excellent | 64.38%Excellent 64.38% Excellent | 17.76%Excellent 17.76% Excellent | 0.10% |
Aster DM Healthcare LtdAster DM Health... ASTERDM • 540975 | 37.2/100 | ₹824.60₹825 | ₹71917.90₹71917.90 | 176.20Average 176.2 Average | 10.70%Average 10.70% Average | 11.40%Average 11.40% Average | 0.49Excellent 0.5 Excellent | 22.57%Excellent 22.57% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Narayana Hrudayalaya LtdNarayana Hruday... NH • 539551 | 68.3/100 | ₹2037.40₹2037 | ₹41592.95₹41592.95 | 48.83Average 48.8 Average | 20.87%Excellent 20.87% Excellent | 15.36%Good 15.36% Good | 1.29Average 1.3 Average | 155.30%Excellent 155.30% Excellent | 25.04%Excellent 25.04% Excellent | 0.22% |
Global Health LtdGlobal Health L... MEDANTA • 543654 | 59.9/100 | ₹1338.50₹1339 | ₹35993.93₹35993.93 | 64.59Average 64.6 Average | 15.17%Good 15.17% Good | 17.14%Good 17.14% Good | 0.30Excellent 0.3 Excellent | 80.71%Excellent 80.71% Excellent | 24.97%Excellent 24.97% Excellent | 0.04% |
13.9/100 | ₹807.95₹808 | ₹33947.05₹33947.05 | 136.88Average 136.9 Average | 11.31%Average 11.31% Average | 9.29%Poor 9.29% Poor | 1.89Average 1.9 Average | 4.19%Average 4.19% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Dr Agarwals Health Care LtdDr Agarwals Hea... AGARWALEYE • 544350 | 48.5/100 | ₹493.75₹494 | ₹15618.15₹15618.15 | 117.89Average 117.9 Average | 6.81%Poor 6.81% Poor | 11.12%Average 11.12% Average | 0.53Good 0.5 Good | 34.42%Excellent 34.42% Excellent | 34.58%Excellent 34.58% Excellent | 0.00% |
60/100 | ₹1499.80₹1500 | ₹9829.95₹9829.95 | 51.90Average 51.9 Average | 13.06%Average 13.06% Average | 14.80%Average 14.80% Average | 0.38Excellent 0.4 Excellent | 142.78%Excellent 142.78% Excellent | 25.27%Excellent 25.27% Excellent | 0.07% | |
42.7/100 | ₹646.85₹647 | ₹9663.25₹9663.25 | 336.09Average 336.1 Average | 2.55%Poor 2.55% Poor | 8.31%Poor 8.31% Poor | 1.30Average 1.3 Average | 17.65%Excellent 17.65% Excellent | 20.33%Excellent 20.33% Excellent | 0.00% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Ltd share price128448.55 Cr
- Max Healthcare Institute Ltd share price107422.79 Cr
- Fortis Healthcare Ltd share price73687.64 Cr
- Aster DM Healthcare Ltd share price71917.90 Cr
- Narayana Hrudayalaya Ltd share price41592.95 Cr
Artemis Medicare Services Ltd Quarterly Performance
Latest quarterly metrics for ARTEMISMED — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
16.61%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
27.37%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
21.41%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
75.56%
Compounded annual net profit growth over 5 years
Artemis Medicare Services Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ARTEMISMED — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Artemis Medicare Services Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Artemis Medicare Services Ltd (ARTEMISMED) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Artemis Medicare Services Ltd
About ARTEMISMED (Artemis Medicare Services Ltd)
Artemis Medicare Services Ltd is a prominent healthcare provider, weaving a tapestry of medical expertise across its network of hospitals. Each facility is a hub of advanced techno...logy and compassionate care, designed to cater to a diverse range of medical needs. From intricate surgical procedures to comprehensive medical management, Artemis hospitals are equipped with state-of-the-art diagnostic tools and treatment modalities. They foster an environment of healing, where patient well-being is at the heart of every endeavor. Artemis remains committed to fostering excellence and setting new standards in the delivery of healthcare services. Beyond the core medical and surgical interventions, Artemis Medicare Services Ltd emphasizes holistic patient care, recognizing the interconnectedness of physical and emotional well-being. Patients and their families benefit from a comprehensive suite of support services. This includes specialized programs like emotional support and counseling, nutritional guidance, and even childcare facilities, easing the burden on families during challenging times. Multilingual medical interpreters facilitate effective communication for international patients, ensuring a seamless and comfortable experience. Artemis proactively promotes a patient-centric approach by actively involving patients and their families in the decision-making process through advisory councils. The Artemis Medicare Services Ltd commitment to excellence is further demonstrated through cutting-edge initiatives like telemedicine and patient portals. These innovations improve accessibility to healthcare. Patients can effortlessly schedule appointments, access their medical records, and communicate with healthcare professionals remotely. The focus on continuous innovation allows Artemis to extend its reach and cater to a growing number of patients across India and internationally. Artemis Medicare strives to provide accessible, affordable, and high-quality healthcare to all.
Company Details
Key Leadership
Corporate Events
ARTEMISMED Share Price: Frequently Asked Questions
What is the current share price of Artemis Medicare Services Ltd?
Artemis Medicare Services Ltd (ARTEMISMED) trades at ₹276.20 on NSE and BSE. Market cap ₹4.38K (Cr). Educational data only.
What is the P/E ratio of Artemis Medicare Services Ltd?
Artemis Medicare Services Ltd has a P/E of 41.39x vs industry average 48.79x.
What is the Bull Run score for Artemis Medicare Services Ltd?
Artemis Medicare Services Ltd has a Bull Run score of 69.5/100 based on 25+ financial parameters.
Does Artemis Medicare Services Ltd pay dividends?
Artemis Medicare Services Ltd has a dividend yield of 0.16%. Past dividends don't guarantee future payments.
What is the ROE of Artemis Medicare Services Ltd?
Artemis Medicare Services Ltd has ROE of 11.88%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Artemis Medicare Services Ltd?
Artemis Medicare Services Ltd has debt-to-equity of 0.28.
Is Artemis Medicare Services Ltd a good investment?
Bull Run gives Artemis Medicare Services Ltd a score of 69.5/100. This is not investment advice — consult a SEBI-registered advisor.